The response to neoadjuvant chemotherapy as a prognostic factor in breast cancer patients

被引：0
|
作者：
Ruiz, C [1 ]
Barros, A [1 ]
Motta, E [1 ]
Pinotti, J [1 ]
机构：
[1] CTR REFERENCIA SAUDE MULHER,SAO PAULO,BRAZIL
来源：
BREAST | 1997年 / 6卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：P949 / P949
页数：1
相关论文
共 50 条
  • [1] Prognostic factors for response to neoadjuvant chemotherapy in patients with breast cancer
    Kang, S. Y.
    Jung, Y. S.
    Kim, K. S.
    [J]. BREAST, 2011, 20 : S48 - S48
  • [2] Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients
    Karatas, Fatih
    Erdem, Gokmen Umut
    Sahin, Suleyman
    Aytekin, Aydin
    Yuce, Deniz
    Sever, Ali R.
    Babacan, Taner
    Ates, Ozturk
    Ozisik, Yavuz
    Altundag, Kadri
    [J]. BREAST, 2017, 32 : 237 - 244
  • [3] Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
    Maria D Cao
    Guro F Giskeødegård
    Tone F Bathen
    Beathe Sitter
    Anna Bofin
    Per E Lønning
    Steinar Lundgren
    Ingrid S Gribbestad
    [J]. BMC Cancer, 12
  • [4] Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
    Cao, Maria D.
    Giskeodegard, Guro F.
    Bathen, Tone F.
    Sitter, Beathe
    Bofin, Anna
    Lonning, Per E.
    Lundgren, Steinar
    Gribbestad, Ingrid S.
    [J]. BMC CANCER, 2012, 12
  • [5] Obesity as an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas, Fatih
    Erdem, Gokmen Umut
    Sahin, Suleyman
    Aytekin, Aydin
    Yuce, Deniz
    Sever, Ali Riza
    Altundag, Kadri
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Prognostic Factor for Partial Responder and Validation of Tumor Response Ratio After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Jung, Seung Pil
    Woo, Sang Wook
    Bae, Jeoung Won
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : 87 - 87
  • [7] Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes
    Yildiz, Anil
    Bilici, Ahmet
    Acikgoz, Ozgur
    Hamdard, Jamshid
    Basim, Pelin
    Cakir, Tansel
    Cakir, Asli
    Olmez, Omer Fatih
    Gezen, Cem
    Yildiz, Ozcan
    [J]. JOURNAL OF CHEMOTHERAPY, 2024,
  • [8] ABCB1 polymorphism as a prognostic factor in breast cancer patients with neoadjuvant chemotherapy
    Kim, Hee Jun
    Im, Seock-Ah
    Ham, Hye Seon
    Lee, Kyung Hun
    Kim, Tae Yong
    Kim, Yu Jeong
    Oh, Do-Youn
    Kim, Jee Hyun
    Han, Wonshik
    Jang, In-Jin
    Kim, Tae-You
    Park, In Ae
    Noh, Dong Young
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Dkk1 as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Breast Cancer Patients
    Kasoha, Mariz
    Steinbach, Anna K.
    Bohle, Rainer M.
    Linxweiler, Barbara
    Haj Hamoud, Bashar
    Doerk, Merle
    Nigdelis, Meletios P.
    Stotz, Lisa
    Zimmermann, Julia S. M.
    Solomayer, Erich-Franz
    Kaya, Askin C.
    Radosa, Julia C.
    [J]. CANCERS, 2024, 16 (02)
  • [10] Is invasive lobular breast cancer a prognostic factor for neoadjuvant chemotherapy response and long term outcomes?
    Julian, T.
    Anderson, S.
    Fourchotte, V
    Zieger, S.
    Mamounas, E.
    Bear, H.
    Costantino, J.
    Wolmark, N.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S146 - S146
12345